Status:
UNKNOWN
Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Eligibility:
All Genders
18+ years
Brief Summary
Although SLE and RA are correlated with genetic predisposing factors such as human leukocyte antigen (HLA) class II, both diseases and other genetic factors might have contributed to the development o...
Detailed Description
Abnormal immune responses permit sustained production of pathogenic subsets of autoantibodies such as anti-DNA, and anti-RNP, anti-RBC, anti-platelet. T cell help is critical to development of full-bl...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- SLE, RA, or healthy
Exclusion
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
End Date :
July 1 2006
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT00172666
Start Date
August 1 2005
End Date
July 1 2006
Last Update
March 30 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chung-Yi Hu
Taipei, Taiwan, 100